Market Overview The Keytruda Market is being propelled forward by the power of combination therapy and the continuous expansion of its label. The shift from monotherapy to pairing pembrolizumab with chemotherapy, targeted agents, and other immunotherapies has significantly improved efficacy across multiple tumor types. Simultaneously, Merck's strategy of pursuing approvals in new indications,...